Recall Z-0228-2019— bioMerieux, Inc.

Class II · Terminated

Class II FDA medical device recall by bioMerieux, Inc., initiated 2018-06-27, terminated 2020-07-21. FDA's recall record names no specific 510(k) clearance for this event. Product: BACT/ALERT VIRTUO system, A Unit, with Version R2.0 Firmware Product Usage: The BacT/ALERT VIRTU Microbial Detection System is an automated microbial test system capable of incubating, agitating, and continuously monitoring for the detection of aerobic, facultative, and anaerobic microorganism growth from blood and other normally sterile body fluids.. Reason: The BACT/ALERT VIRTUO Instrument Firmware version R2.0 allows relocation of the four (4) resident calibration standards so that Field System Engineers (FSE) can service the associated cells P24 - P27, where the calibration standards typically reside. If the calibration standards are not returned to the designated locations, an anomaly may occur..

Recalling firm
bioMerieux, Inc.
Classification
Class II
Status
Terminated
Initiated
2018-06-27
Terminated
2020-07-21
Firm location
Durham, NC, United States

Product description

BACT/ALERT VIRTUO system, A Unit, with Version R2.0 Firmware Product Usage: The BacT/ALERT VIRTU Microbial Detection System is an automated microbial test system capable of incubating, agitating, and continuously monitoring for the detection of aerobic, facultative, and anaerobic microorganism growth from blood and other normally sterile body fluids.

Reason for recall

The BACT/ALERT VIRTUO Instrument Firmware version R2.0 allows relocation of the four (4) resident calibration standards so that Field System Engineers (FSE) can service the associated cells P24 - P27, where the calibration standards typically reside. If the calibration standards are not returned to the designated locations, an anomaly may occur.

Data sourced from openFDA. This site is unofficial and independent of the FDA.